Cells in both tumor models retained proliferative and immature characteristics, as evidenced by c-MYC overexpression and increased MKI67 expression, and decreased expression of MAP2 and GFAP compared to their respective controls (Figures 8A–8D). The gene discussed is MYC; the disease is neoplasm.